Integral Health Asset Management’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.49M Buy
+30,000
New +$8.65M 0.34% 66
2024
Q2
Sell
-50,000
Closed -$12.1M 83
2024
Q1
$12.1M Sell
50,000
-20,000
-29% -$4.6M 1.13% 37
2023
Q4
$14.4M Sell
70,000
-40,000
-36% -$7.81M 1.96% 15
2023
Q3
$19.8M Buy
110,000
+84,000
+323% +$15.5M 2.74% 11
2023
Q2
$5M Buy
+26,000
New +$4.5M 0.62% 55
2021
Q4
Sell
-40,000
Closed -$4.78M 74
2021
Q3
$4.78M Sell
40,000
-30,000
-43% -$3.6M 1.37% 26
2021
Q2
$8.01M Buy
+70,000
New +$8.27M 2.21% 16
2021
Q1
Sell
-70,000
Closed -$6.84M 75
2020
Q4
$6.84M Sell
70,000
-30,000
-30% -$3M 2.04% 21
2020
Q3
$9.69M Buy
100,000
+10,000
+11% +$994K 2.96% 9
2020
Q2
$9.07M Buy
+90,000
New +$8.29M 2.72% 8

Other funds holding COR

Integral Health Asset Management's COR Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in Cencora (COR) in Q2 2026: 30,000 shares worth $8.49M. The stake represents 0.34% of the portfolio and ranks #66 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in COR as recently as Q1 2024.

Integral Health Asset Management first reported a position in COR in Q2 2020 and has held it in 10 quarters since. The position peaked at $19.8M in Q3 2023. 1,348 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • Integral Health Asset Management held 30,000 shares of Cencora worth $8.49M as of Q2 2026.
  • Cencora was a new Integral Health Asset Management position in Q2 2026.
  • Cencora made up 0.34% of Integral Health Asset Management's portfolio in Q2 2026, its #66 holding.
  • Integral Health Asset Management first reported a position in Cencora in Q2 2020 and has held it in 10 quarters since.
  • Integral Health Asset Management's Cencora position peaked at $19.8M in Q3 2023.
  • 1,348 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.